within Pharmacolibrary.Drugs.ATC.B;

model B02BD08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.645,
    adminDuration  = 600,
    adminMass      = 0.09,
    adminCount     = 1,
    Vd             = 0.142,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Coagulation factor VIIa (recombinant) is a hemostatic agent used for treatment and prevention of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or IX, congenital factor VII deficiency, Glanzmann's thrombasthenia, and other acquired bleeding disorders. It is approved and widely used in clinical practice, particularly in emergency situations for controlling major bleeding.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers (both sexes), intravenous bolus administration.</p><h4>References</h4><ol><li>Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler, Nancy Valente, Elina Asikanius, Gallia G Levy, Jerzy Windyga, Midori Shima,Emicizumab Prophylaxis in Hemophilia A with Inhibitors.,The New England journal of medicine,2017<a href='https://pubmed.ncbi.nlm.nih.gov/28691557/'>https://pubmed.ncbi.nlm.nih.gov/28691557/</a></li><li>Joe Salas, Tongyao Liu, Qi Lu, John D Kulman, Tamera Ashworth, Elena Kistanova, Nancy Moore, Glenn F Pierce, Haiyan Jiang, Robert Peters,Enhanced Pharmacokinetics of Factor VIIa as a Monomeric Fc Fusion.,Thrombosis research,2015<a href='https://pubmed.ncbi.nlm.nih.gov/25721936/'>https://pubmed.ncbi.nlm.nih.gov/25721936/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B02BD08;
